Home
Home
/
Products
Products
/
Bioactive Compounds
Bioactive Compounds
/
PI3K/Akt/mTOR Pathway
PI3K/Akt/mTOR Pathway
/
GSK-3
GSK-3
GSK-3
Products (10)
Laduviglusib trihydrochloride
CAS No.:
1782235-14-6
2-[2-(cyclopropanecarbonylamino)pyridin-4-yl]-4-methoxy-1,3-thiazole-5-carboxamide
CAS No.:
1702428-31-6
2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]-1H-indole-5-carbonitrile
CAS No.:
612487-72-6
3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-4-imidazo[1,2-a]pyridin-3-ylpyrrole-2,5-dione
CAS No.:
603288-22-8
5-(3-chloro-4-methoxyphenyl)-N-[3-(1,2,4-triazol-1-yl)propyl]-1,3-oxazole-4-carboxamide
CAS No.:
1962178-27-3
C24:1-Ceramide
CAS No.:
54164-50-0
Tideglusib
CAS No.:
865854-05-3
Elraglusib
CAS No.:
1034895-42-5
AZD2858
CAS No.:
486424-20-8
SB 216763
CAS No.:
280744-09-4
Products
CDMO Compounds
API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact